Curing Cancer: Precision Targeted Medicine
Hosted by Robert Langer, ScD, MIT Institute Professor and cofounder of Moderna
◕‿◕RSVP by e-mail: https://www.mixily.com/event/5408960460278984793
MIT will be holding a tribute to Dr. Saul Hertz (1905-1950), the originator of the medical uses of radioiodine (RAI) and the Father of Theranostics.
The event will be held at the Luria Auditorium 500 Main Street Cambridge, MA between Ames Street and Vassar Street, two blocks from the Kendall/MIT subway station on the MBTA red line at the edge northern edge of the MIT campus in Cambridge.
Parking garages are nearby. Open to The MIT Community and to the public at no charge.
AGENDA:
Barbara Hertz, M.ED. Curator saulhertzmd.com:
"The Birth of Radionuclides in Medicine at MIT/MGH"
MIT's Prof. Robert Langer, ScD:
"Carrying the Legacy Forward"
Dr. Ilya Gipp, MD, PhD – Chief Medical Officer at GE HealthCare:
“Beyond the Half-Life: Linking a Discovery of the Past to the Future of Cancer Care”
David Gilmore, Ed.D.
President, 2027-2028, SNMMI-TS,
Massachusetts College of Pharmacy & Health Sciences, Associate Professor, Nuclear Medicine
"Theranostics: Building a Critical Workforce"
Coffee break
Dana Farber's Dr. Annick Van Den Abbeele, MD:
"TME. Targeting Theranostics: Characterizing the interplay between the TME co-conspirators for more effective therapy”.
MGH Julie Price. Ph.D:
"The Importance of Nuclear Medicine Imaging in Aging and Neurodegeneration"
Jason Dearling, Ph.D VP Radio-Pharmaceuticals, Mariana Oncology/Novartis:
"Targeting Radioligand Therapy for the treatment of Small Cell Lung Cancer(SCLC) and Beyond"
Sheryl Mosessian, PH.D. Chief Scientific Officer, SOFIE:
"Probing Potential: "How to Find Success Leveraging Academic-Biotech Partnerships"
Panel Discussion and Questions
Guest List
˜▾˜
*⏖*
❛ᴗ❛